지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한정신약물학회 Clinical Psychopharmacology and Neuroscience Clinical Psychopharmacology and Neuroscience 제21권 제1호
- 발행연도
- 2023.2
- 수록면
- 202 - 206 (5page)
- DOI
- 10.9758/cpn.2023.21.1.202
이용수
초록· 키워드
오류제보하기
Treatment-resistant schizophrenia (TRS) poses a significant therapeutic challenge in psychiatric practice. Clozapine is recognized as a treatment of choice in TRS but is not always effective in alleviating patients’ symptoms. Additionally, clozapine therapy is associated with multiple side effects and monitoring requirements that often limit its use and neg atively affect patients’ compliance with the treatment. Although clozapine augmentation options are available, there is currently no alternative monotherapy proven to be effective in TRS. We present a case of a young man with TRS who failed to respond to appropriate trials of risperidone, aripiprazole and also clozapine, and who experienced impair ing adverse effects of clozapine that made further clozapine treatment not only futile but also detrimental to his health.
He was successfully treated with cariprazine monotherapy, which culminated in the remission of his both positive and negative symptoms of psychosis as well as in the marked improvement in social functioning. Cariprazine, a newer atypical antipsychotic endowed with a D3-preferring mode of action, may offer a better tolerated and more acceptable treatment option for patients with difficult-to-treat psychotic symptoms.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases
Clinical Psychopharmacology and Neuroscience
2021 .01
-
치료저항성 조현병에서 클로자핀 치료의 현황
대한조현병학회지
2021 .01
-
치료저항성 조현병: 정의와 임상양상
대한조현병학회지
2020 .01
-
치료 위저항성 조현병: 치료 비순응을 중심으로
대한조현병학회지
2020 .01
-
Current Unmet Needs and Clues to the Solution in the Management of Tricuspid Regurgitation
Korean Circulation Journal
2022 .06
-
‘2019 한국형 조현병 약물치료 지침서’에 따른 조현병에서 동반증상 및 부작용의 치료
대한조현병학회지
2019 .01
-
치료 저항성 조현병 환자와 치료 반응성 조현병 환자간의 CRP를 포함한 염증 표지자 비교
생물치료정신의학
2019 .10
-
조현병 약물치료의 최신 지견
대한의사협회지
2024 .02
-
Korean Medication Algorithm for Schizophrenia 2019, Second Revision: Treatment of Psychotic Symptoms
Clinical Psychopharmacology and Neuroscience
2020 .01
-
항정신병약물에 의한 대사부작용에 대한 이론과 대처방안
신경정신의학
2019 .01
-
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
Clinical Psychopharmacology and Neuroscience
2021 .11
-
조현병 환자에서 항정신병약물 유지치료 시 치료결과에 대한 연구
대한조현병학회지
2017 .10
-
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
전남의대학술지
2020 .01
-
Augmentation Strategies for Partial or Non-responders to Clozapine in Patients with Schizophrenia: A Bayesian Network Meta-analysis of Randomized Controlled Trials
Clinical Psychopharmacology and Neuroscience
2024 .05
-
Clozapine in the Time of COVID-19
Clinical Psychopharmacology and Neuroscience
2020 .01
-
한국형 양극성 장애 약물치료 알고리듬 2022: 조증 삽화
신경정신의학
2022 .05
-
Association of the First Antipsychotic Treatment Duration With the Re-Initiation of Treatment in Schizophrenia: A National Health Insurance Data-Based Study
대한조현병학회지
2021 .10
-
클로자핀의 지연된 사용이 치료저항성 조현병 환자의 급성기 약물 반응에 미치는 영향
대한조현병학회지
2021 .10
-
Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
Clinical Psychopharmacology and Neuroscience
2017 .01
-
Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia
PSYCHIATRY INVESTIGATION
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0